Talk 1: Dr Natalie Cook, The Christie NHS Foundation Trust - Unknown Primary, Known Target: The Agnostic Approach to Precision Oncology


Talk 2: A/Prof Jia (Jenny) Liu, St Vincent’s Hospital Sydney -PANNACOTA Final Analysis – Synergies from liquid biopsy and a phase 1 network


Talk 3: Dr Udit Nindra, Wollongong and Liverpool Hospitals - Financial, social and time toxicity in early-phase cancer clinical trials: The PEARLER study


Talk 4: Prof Aaron Hanson, Princess Alexandra Hospital Brisbane - Patient Reported Outcomes toolkit for Phase I trials


Talk 5: Dr Rachel Galimidi, Garvan Institute of Medical Research - Discovery and translation, trials and tribulations

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör NSW Early Phase Clinical Trials Alliance (NECTA). Innehållet i podden är skapat av NSW Early Phase Clinical Trials Alliance (NECTA) och inte av, eller tillsammans med, Poddtoppen.